NOCD, a Chicago, IL-based provider of obsessive compulsive-disorder (OCD) treatment, closed a $33m Series B funding round.
The round was led by F-Prime Capital, with participation from Eight Roads Ventures, and Kaiser Permanente Ventures participating along with existing investors including 7wireVentures, Health Enterprise Partners (HEP), and Chicago Ventures.
The company intends to use the funds to expand its community, reach people earlier in their treatment journey, and offer additional services to assist with their long-term health.
Led by Stephen Smith, Chief Executive Officer and founder, NOCD is a telehealth provider for the treatment of obsessive- compulsive disorder (OCD) and a Community-Driven Therapy company which helps people reclaim their lives with clinically proven OCD treatment by removing barriers to care, and by reducing the stigma associated with OCD. Inside the NOCD platform, members can quickly access a national network of licensed therapists that specialize in Exposure and Response Prevention (ERP), the “gold standard” for OCD treatment.
The company is now delivering more than 12,000 live telehealth visits per month.